Natco investor presentation highlights drugs where they are FTF in 10 drugs. All of them are 100 mn usd+(many are billion usd + ) market size drugs. While launch dates are in future but pretty deep pipeline.
Also there subs are performing well. To better use the drugs in portfolio over a larger market.
They are planning an acquisition in india to get into new therapy areas.
Ctpr sales will start from this qtr that will help lower inventory levels. 6 to 7 drugs are planned in agri to round up the portfolio . All of them with similar market size as ctpr.agri exports after domestic stabilizes.
| Subscribe To Our Free Newsletter |
